Showing results (21-30 of 48) with videos related to

Sort By:
Pageof 5
Infection|December 28, 2016
Management of HCV infection in the penitentiary setting in the direct-acting antivirals era: practical recommendations from an expert panelRoberto Ranieri, Giulio Starnini, Sergio Carbonara, et al.
Infection and Drug Resistance|August 3, 2019
Viral dynamics among HCV infected patients with different genotypes treated with genotypic specific or pan-genotypic direct-acting antiviral agent combinationsStefania Paolucci, Federica Novazzi, Antonio Piralla, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|May 21, 2011
Correlation between FIB4, liver stiffness and metabolic parameters in patients with HIV and hepatitis C virus co-infectionRaffaele Bruno, Paolo Sacchi, Serena Cima, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|November 23, 2020
Feasibility and efficacy of 8 week Glecaprevir/Pibrentasvir to treat incarcerated viraemic HCV patients: A case-control studyVito Fiore, Roberto Ranieri, Serena Dell'Isola, et al.
Viruses|February 29, 2020
Baseline Amino Acid Substitutions in the NS5A ISDR and PKR Binding Domain of Hepatitis C and Different Fibrosis Levels and Levels of Development of Hepatocellular Carcinoma in Patients Treated with DAAsStefania Paolucci, Antonio Piralla, Federica Novazzi, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|November 15, 2003
Good safety profile and efficacy of leucocyte interferon-alpha in combination with oral ribavirin in treatment-naive patients with chronic hepatitis C: a multicentre, randomised, controlled studyGiuseppe Barbaro, Benvenuto Grisorio, Luigi Fruttaldo, et al.
Scientific Reports|November 24, 2017
Baseline and Breakthrough Resistance Mutations in HCV Patients Failing DAAsStefania Paolucci, Marta Premoli, Stefano Novati, et al.
The International Journal on Drug Policy|July 10, 2018
Treatment with direct-acting antivirals in a multicenter cohort of HCV-infected inmates in ItalyEmanuele Pontali, Vito Fiore, Anna Maria Ialungo, et al.
Plos One|October 15, 2016
Switch to Dolutegravir plus Rilpivirine Dual Therapy in cART-Experienced Subjects: An Observational CohortAmedeo F Capetti, Gaetana Sterrantino, Maria Vittoria Cossu, et al.
Viruses|February 28, 2023
Women Living with HIV in Italian Prison Settings: Results from the Gender-Specific ROSE NetworkElena Rastrelli, Vito Fiore, Roberto Ranieri, et al.
Pageof 5